GSK Investigational Site

Cona (FE), Emilia-Romagna 44124

0 studies enrolling now · 2 studies all time

What they study most

Herpes Zoster, Respiratory Disorders

Studies at this site

• A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response. — Completed
• Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A — Completed